in this issue
Regions :: Western Europe :: Netherlands
DSM signs biologics development and manufacturing agreement with Australian firm
4:53 AM MDT | October 30, 2012 | Deepti Ramesh
DSM Pharmaceutical Products (Parsippany, NJ), the business unit of DSM which provides contract manufacturing and development services to the pharma and biopharma industries, says it has signed a biologics contract manufacturing agreement with Paranta Biosciences (Melbourne). Financial terms were not disclosed. Paranta Biosciences is an early stage drug development company that develops and commercializes biotherapeutics based on recombinant human follistatin for the treatment of respiratory diseases. The contract covers the process development and manufacture by...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee